1. Pfaller MA, Jones RN, Doern GVet al.International surveillance of blood stream infections due toCandidaspecies in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe). Diagn Microbiol Infect Dis 1999;35:19–25.
2. Pfaller MA, Messer SA, Hollis RJet al.Trends in species distribution and susceptibility to fluconazole among blood stream isolates ofCandidaspecies in the United States. Diagn Microbiol Infect Dis 1999;33:217–22.
3. Pfaller MA, Jones RN, Doern GV, Sader HS, Hollis RJ, Messer SA. International surveillance of bloodstream infections due toCandidaspecies: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group. J Clin Microbiol 1998;36:1886–9.
4. Pavese P, Brion JP, Lebeau B, Grillot R, Ambroise Thomas P. Epidemiology of fungemia in a university hospital; therapeutic incidence. Pathol Biol Paris 1999;47:57983.
5. Cartledge JD, Midgley J, Gazzard BG. Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis. AIDS 1997;11:183944.